XML 59 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2020
Derivative Financial Instruments  
Derivative Financial Instruments

NOTE T. DERIVATIVE FINANCIAL INSTRUMENTS

The company operates in multiple functional currencies and is a significant lender and borrower in the global markets. In the normal course of business, the company is exposed to the impact of interest rate changes and foreign currency fluctuations, and to a lesser extent equity and commodity price changes and client credit risk. The company limits these risks by following established risk management policies and procedures, including the use of derivatives, and, where cost effective, financing with debt in the currencies in which assets are denominated. For interest rate exposures, derivatives are used to better align rate movements between the interest rates associated with the company’s lease and other financial assets and the interest rates associated with its financing debt. Derivatives are also used to manage the related cost of debt. For foreign currency exposures, derivatives are used to better manage the cash flow volatility arising from foreign exchange rate fluctuations.

In the Consolidated Balance Sheet, the company does not offset derivative assets against liabilities in master netting arrangements nor does it offset receivables or payables recognized upon payment or receipt of cash collateral against the fair values of the related derivative instruments. No amount was recognized for the right to reclaim or the obligation to return cash collateral at December 31, 2020 and $26 million was recognized in other accounts receivable for the right to reclaim cash collateral at December 31, 2019. The company restricts the use of cash collateral received to rehypothecation, and therefore reports it in restricted cash in the Consolidated Balance Sheet. No amount was rehypothecated at December 31, 2020 and 2019. Additionally, if derivative exposures covered by a qualifying master netting agreement had been netted in the Consolidated Balance Sheet at December 31, 2020 and 2019, the total derivative asset and liability positions each would have been reduced by $213 million and $194 million, respectively.

In its hedging programs, the company may use forward contracts, futures contracts, interest-rate swaps, cross-currency swaps, equity swaps, and options depending upon the underlying exposure. The company is not a party to leveraged derivative instruments.

A brief description of the major hedging programs, categorized by underlying risk, follows.

Interest Rate Risk

Fixed and Variable Rate Borrowings

The company issues debt in the global capital markets to fund its operations and financing business. Access to cost-effective financing can result in interest rate mismatches with the underlying assets. To manage these mismatches and to reduce overall interest cost, the company may use interest-rate swaps to convert specific fixed-rate debt issuances into variable-rate debt (i.e., fair value hedges) and to convert specific variable-rate debt issuances into fixed-rate debt (i.e., cash flow hedges). At December 31, 2020 and 2019, the total notional amount of the company’s interest-rate swaps was $3.0 billion at both periods. The weighted-average remaining maturity of these instruments at December 31, 2020 and 2019 was approximately 1.2 years and 2.2 years, respectively. These interest-rate contracts were accounted for as fair value hedges. The company did not have any cash flow hedges relating to this program outstanding at December 31, 2020 and 2019.

Forecasted Debt Issuance

The company is exposed to interest rate volatility on future debt issuances. To manage this risk, the company may use instruments such as forward starting interest-rate swaps to lock in the rate on the interest payments related to the forecasted debt issuances. In the second quarter of 2019, the company issued an aggregate of $20 billion of indebtedness (refer to note P, “Borrowings,” for additional information). Following the receipt of the net proceeds from this debt offering, the company terminated $5.5 billion of forward starting interest-rate swaps. There were no instruments outstanding at December 31, 2020 and 2019.

In connection with cash flow hedges of forecasted interest payments related to the company’s borrowings, the company recorded net losses of $174 million and net losses of $192 million (before taxes) at December 31, 2020 and 2019, respectively, in AOCI. The company estimates that $18 million (before taxes) of the deferred net losses on derivatives in AOCI at December 31, 2020 will be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying interest payments.

Foreign Exchange Risk

Long-Term Investments in Foreign Subsidiaries (Net Investment)

A large portion of the company’s foreign currency denominated debt portfolio is designated as a hedge of net investment in foreign subsidiaries to reduce the volatility in stockholders’ equity caused by changes in foreign currency exchange rates in the functional currency of major foreign subsidiaries with respect to the U.S. dollar. At December 31, 2020 and 2019, the carrying value of debt designated as hedging instruments was $16.4 billion and $7.3 billion, respectively. The $9.0 billion increase is part of the company’s risk management strategy and is primarily the result of the designation of new issuances in the first quarter of 2020 and previously hedged Euro-denominated debt. The company also uses cross-currency swaps and foreign exchange forward contracts for this risk management purpose. At December 31, 2020 and 2019, the total notional amount of derivative instruments designated as net investment hedges was $7.2 billion and $7.9 billion, respectively. At December 31, 2020 and 2019, the weighted-average remaining maturity of these instruments was approximately 0.3 years and 0.1 years, respectively.

Anticipated Royalties and Cost Transactions

The company’s operations generate significant nonfunctional currency, third-party vendor payments and intercompany payments for royalties and goods and services among the company’s non-U.S. subsidiaries and with the company. In anticipation of these foreign currency cash flows and in view of the volatility of the currency markets, the company selectively employs foreign exchange forward contracts to manage its currency risk. These forward contracts are accounted for as cash flow hedges. The maximum remaining length of time over which the company has hedged its exposure to the variability in future cash flows is approximately four years. At December 31, 2020 and 2019, the total notional amount of forward contracts designated as cash flow hedges of forecasted royalty and cost transactions was $8.0 billion and $9.7 billion, respectively. At December 31, 2020 and 2019, the weighted-average remaining maturity of these instruments was approximately 0.7 years and 0.8 years, respectively.

At December 31, 2020 and 2019, in connection with cash flow hedges of anticipated royalties and cost transactions, the company recorded net losses of $192 million and net gains of $145 million (before taxes), respectively, in AOCI. The company estimates that $285 million (before taxes) of deferred net losses on derivatives in AOCI at December 31, 2020 will be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying anticipated transactions.

Foreign Currency Denominated Borrowings

The company is exposed to exchange rate volatility on foreign currency denominated debt. To manage this risk, the company employs cross-currency swaps to convert fixed-rate foreign currency denominated debt to fixed-rate debt denominated in the functional currency of the borrowing entity. These swaps are accounted for as cash flow hedges. At December 31, 2020, the maximum length of time remaining over which the company has hedged its exposure was approximately seven years. At December 31, 2020 and 2019, the total notional amount of cross-currency swaps designated as cash flow hedges of foreign currency denominated debt was $1.5 billion and $8.2 billion, respectively. The primary driver of the $6.7 billion decrease in cross-currency swaps is part of the company’s risk management strategy to use the previously hedged foreign currency denominated debt as a hedge of net investment in foreign subsidiaries.

At December 31, 2020 and 2019, in connection with cash flow hedges of foreign currency denominated borrowings, the company recorded net losses of $236 million and net losses of $185 million (before taxes), respectively, in AOCI. The company estimates that $23 million (before taxes) of deferred net losses on derivatives in AOCI at December 31, 2020 will be reclassified to net income within the next 12 months, providing an offsetting economic impact against the underlying exposure.

Subsidiary Cash and Foreign Currency Asset/Liability Management

The company uses its Global Treasury Centers to manage the cash of its subsidiaries. These centers principally use currency swaps to convert cash flows in a cost-effective manner. In addition, the company uses foreign exchange forward contracts to economically hedge, on a net basis, the foreign currency exposure of a portion of the company’s nonfunctional currency assets and liabilities. The terms of these forward and swap contracts are generally less than one year. The changes in the fair values of these contracts and of the underlying hedged exposures are generally offsetting and are recorded in other (income) and expense in the Consolidated Income Statement. At December 31, 2020 and 2019, the total notional amount of derivative instruments in economic hedges of foreign currency exposure was $6.8 billion and $7.1 billion, respectively.

Equity Risk Management

The company is exposed to market price changes in certain broad market indices and in the company’s own stock primarily related to certain obligations to employees. Changes in the overall value of these employee compensation obligations are recorded in SG&A expense in the Consolidated Income Statement. Although not designated as accounting hedges, the company utilizes derivatives, including equity swaps and futures, to economically hedge the exposures related to its employee compensation obligations. The derivatives are linked to the total return on certain broad market indices or the total return on the company’s common stock, and are recorded at fair value with gains or losses also reported in SG&A expense in the Consolidated Income Statement. At December 31, 2020 and 2019, the total notional amount of derivative instruments in economic hedges of these compensation obligations was $1.3 billion at both periods.

Cumulative Basis Adjustments for Fair Value Hedges

At December 31, 2020 and 2019, the following amounts were recorded in the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:

($ in millions)

At December 31:

    

2020

    

2019

Short-term debt:

 

  

 

  

Carrying amount of the hedged item

 

$

(1,302)

 

$

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)

(2)

Long-term debt:

Carrying amount of the hedged item

 

(2,097)

 

(3,411)

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)*

(424)

(440)

* Includes ($353) million and ($404) million of hedging adjustments on discontinued hedging relationships at December 31, 2020 and 2019, respectively.

The Effect of Derivative Instruments in the Consolidated Income Statement

The total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value hedges, cash flow hedges, net investment hedges and derivatives not designated as hedging instruments are recorded and the total effect of hedge activity on these income and expense line items are as follows:

($ in millions)

Gains/(Losses) of

Total

 

Total Hedge Activity

For the year ended December 31:

    

2020

    

2019

    

2018

    

2020

    

2019

    

2018

Cost of services

 

$

30,404

$

32,491

$

33,687

$

23

$

68

$

30

Cost of sales

6,934

7,263

7,835

2

51

8

Cost of financing

708

904

1,132

12

(42)

(6)

SG&A expense

23,082

20,604

19,366

141

267

(116)

Other (income) and expense

861

(968)

1,152

101

(15)

(434)

Interest expense

1,288

1,344

723

35

(93)

(6)

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement

Consolidated

Recognized on

Attributable to Risk

Income Statement

Derivatives

Being Hedged (2)

For the year ended December 31:

    

 Line Item

    

2020

    

2019

    

2018

    

2020

    

2019

    

2018

Derivative instruments in fair value hedges (1)

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

Cost of financing

 

$

20

$

44

$

(61)

$

4

$

(32)

$

97

 

Interest expense

 

58

98

(58)

11

(71)

92

Derivative instruments not designated as hedging instruments

 

Foreign exchange contracts

 

Other (income)
and expense

 

1

(53)

(93)

N/A

N/A

N/A

Equity contracts

 

SG&A expense

 

142

214

(116)

N/A

N/A

N/A

Total

 

  

$

220

$

302

$

(327)

$

14

$

(103)

$

189

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income

Consolidated

Reclassified

Amounts Excluded from

For the year ended

Recognized in OCI  

Income Statement 

from AOCI  

Effectiveness Testing (3)

December 31:

   

2020

   

2019

   

2018

   

 Line Item

   

2020

   

2019

   

2018

   

2020

   

2019

   

2018

Derivative instruments in cash flow hedges

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

$

$

(168)

$

(35)

 

Cost of financing

$

(5)

$

(3)

$

$

$

$

 

Interest expense

(13)

(8)

Foreign exchange contracts

(349)

(521)

(101)

 

Cost of services

23

68

30

 

Cost of sales

2

51

8

 

Cost of financing

(23)

(86)

(75)

 

SG&A expense

0

53

0

 

Other (income)
and expense

101

39

(341)

 

Interest expense

(65)

(190)

(71)

Instruments in net investment hedges (4)

 

  

Foreign exchange contracts

(2,127)

(95)

686

 

Cost of financing

16

35

33

 

Interest expense

45

77

31

Total

$

(2,477)

$

(784)

$

549

 

  

$

21

$

(75)

$

(449)

$

60

$

112

$

64

(1)The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.
(2)The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.
(3)The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period.
(4)Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.

N/A–Not applicable

For the years ending December 31, 2020, 2019 and 2018, there were no material gains or losses excluded from the assessment of hedge effectiveness (for fair value or cash flow hedges), or associated with an underlying exposure that did not or was not expected to occur (for cash flow hedges); nor are there any anticipated in the normal course of business.